Military Vestibular Assessment and Rehabilitation Advanced Conference

March 24, 2025 to March 27, 2025

Program Description: 

This live event is designed for clinicians who have experience assessing and treating individuals with vestibular hypofunction and benign paroxysmal positional vertigo. The course provides advanced training in common complex disorders such as concussion, migraine, and Meniere’s disease; surgical and pharmaceutical interventions; psychogenic considerations; and other considerations when working with individuals with complex dizziness in the military. The Advanced Course features didactic instruction covering vestibular function test interpretation (Rotary Chair Testing, vHIT and VEMPs). The primary target audience for this course includes physical and occupational therapists, audiologists, and physicians treating military beneficiaries and Veterans in Defense Health Agency and Department of Veterans Affairs health care facilities.

Target Audience

This activity provides continuing education for physicians, physician assistants, physical therapists, audiologists and occupational therapists. A certificate of attendance is available for other attendees.

Learning Objectives

24 March 2025 – Day 1

  1. Identify the most common signs and symptoms of Superior Semicircular Canal Dehiscence (SSCD)
  2. Evaluate a computed tomography (CT) scan for the presence of SSCD
  3. Describe surgical approaches for repair of SSCD
  4. Describe the clinical criteria required for the diagnosis of Meniere’s Disease (MD)
  5. Summarize effective pharmacological and non-surgical interventions for the management of MD
  6. Compare pros and cons of surgical treatments for MD
  7. Define the best montage for Ocular Vestibular Evoked Myogenic Potentials (VEMP) and Reference Contamination
  8. Describe how VEMP testing can be useful with Vestibular Migraine
  9. Explain the use of VEMP to differential Superior and Inferior Vestibular Nerve Impairments.
  10. Understand the physiology underlying vestibular evoked myogenic potential (VEMP) testing
  11. Understand how VEMP testing is performed in the clinic
  12. Understand how to interpret VEMP testing

25 March 2025 – Day 2

  1. Identify vHIT artifact and potential causes
  2. Identify normal vs abnormal VOR gain values
  3. Recognize covert and overt saccades
  4. Monitor and identify insufficient head velocity speeds
  5. Describe the importance of autonomic dysfunction after concussion.
  6. Describe how to assess exercise tolerance after concussion.
  7. Describe how to prescribe sub-symptom threshold aerobic exercise early after injury to facilitate recovery from sport-related concussion (SRC).
  8. Identify various tests to assess the peripheral vestibular pathways
  9. Learn the variability in test findings in chronic dizzy mTBI patients
  10. Recognize the complex, time-intensive and fatiguing effects of comprehensive testing for chronic dizzy mTBI patients
  11. Recognize the gaps in research for understanding the etiology of chronic dizziness symptoms in mTBI patients
  12. Demonstrate two possible methods to treat posterior canal BPPV.
  13. Demonstrate two possible methods to treat horizontal canal BPPV
  14. Discuss the connection between sleep position and BPPV.
  15. Discuss current proposed pathophysiology of apogeotropic horizontal canal BPPV.

26 March 2025 – Day 3

  1. Describe the evolution of functional disorders to its modern day definition
  2. Identify 3 additional questions to ask a patient who complains of dizziness
  3. Name 2 psychiatric disorders where dizziness is part of the presentation
  4. List 3 treatment options in this patient population
  5. Explain the variability in test findings in chronic dizzy mTBI patients
  6. Describe psychiatric symptoms seen in patients with chronic dizziness
  7. Formulate assessment plans for vestibular and neurologic causes of chronic dizziness
  8. Defend the clinical implications of vestibulo-ocular reflex (VOR) phase with respect to pathology and compensation
  9. Appraise the benefits and limitations for advanced rotational test protocols
  10. Critically reflect on key components of a complex dizzy clinical case to offer differential diagnosis.
  11. Critically reflect on key components of a complex dizzy clinical case to offer treatment suggestions.

27 March – Day 4

  1. Describe neuro-optometry’s role in the care of the brain injured patient
  2. Understand the importance of eyewear for brain injured patients
  3. Describe treatment for photophobia
  4. Describe the diagnosis and treatment of abnormal egocentric localization
  5. Give an example of a therapy procedure for saccades and pursuits
  6. Identify interdisciplinary team members at the Intrepid Spirit Center Fort Belvoir
  7. Identify barriers involved with interdisciplinary care in an outpatient setting
  8. Discuss anomalous health incidents exposures and outcomes

Additional Information

ASHA Course Type: 
Advanced
Course summary
Available credit: 
  • 19.75 Physician Assistants (AAPA)
    DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.75 hours of AAPA Category 1 CME credits. Approval is valid until Thursday, April 10, 2025 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
  • 19.75 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 19.75 hours for completing this Course activity.
  • 19.75 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 19.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 19.50 Occupational Therapists and Occupational Therapy Assistants (AOTA)
    The DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# 07755. This Blended/Hybrid course is offered at 1.95 CEUs, OT service delivery. AOTA does not endorse specific course content, products, or clinical procedures.
  • 19.50 Physical Therapists and Physical Therapy Assistants (APTA)
    DHA, J-7, CEPO is an American Physical Therapy Association (APTA) Approved Provider of continuing education. This activity was planned by and for the health care team, and learners will receive 1.95 APTA CEUs. The assignment of APTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by APTA. APTA CEUs are accepted by most state PT licensing boards. Learners are encouraged to check with their local chapter or state board to ensure that they accept APTA accredited courses for licensure renewal.
  • 19.50 Speech-Language Pathologists and Audiologists (ASHA)

    Course # is ABIT2504

    Advanced Level

    1.95 ASHA CEUs

    DHA, J-7, CEPO is approved by the Continuing Education board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology, and audiology. ASHA CE Provider approval and use of the Brand Block does not imply endorsement of course content, specific products or clinical procedures.

  • 19.75 Certificate of Attendance
  • 19.75 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 19.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

Course opens: 
03/17/2025
Course expires: 
04/10/2025
Event starts: 
03/24/2025 - 8:00am EDT
Event ends: 
03/27/2025 - 1:00pm EDT
Add to calendar: 
Fort Belvoir, VA
United States

COL Shannon Ford, M.D., DFAPA. Presenter has no financial or non-financial relationships to disclose. COL Ford will be discussing off-label use purposes of venlafaxine (generic).

LTC Anthony Tolisano, M.D. Presenter has no financial or non-financial relationships to disclose. LTC Tolisano will be discussing off-label use purposes of Betahistine.

Michael Schubert, D.P.T. Presenter has no financial or non-financial relationships to disclose.

Christopher K. Zalewski, Ph.D. Presenter has no financial or non-financial relationships to disclose.

Devin McCaslin, Ph.D., F-ASHA. Presenter has no financial or non-financial relationships to disclose.

Carrie Hoppes, P.T., Ph.D., NCS, OCS, ATC, CSCS. Presenter has no financial or non-financial relationships to disclose.

John Leddy, M.D. must disclose his membership of the Advisory Boards for: Highmark Innovations, Neuronasal, Quadrant Biosciences, and Noggin Health. He also holds minority stock options in Highmark Innovations, 360 Concussion Care, and Noggin Health. Dr. Leddy also receives grant and/or research support from NIH and the Department of Defense (DoD).

Robin Pinto, Au.D. Presenter has no financial or non-financial relationships to disclose.

Karen Lambert, D.P.T., NCS. Presenter has no financial or non-financial relationships to disclose.

Stephanie Beauregard, M.P.T. Presenter has no financial or non-financial relationships to disclose.

All relevant financial relationships have been resolved.

Richard Clendaniel, Ph.D. Presenter has no financial or non-financial relationships to disclose.

All relevant financial relationships have been resolved.

Disclosure: DHA J-7 staff, planning committee members, and content reviewers have no financial interest to disclose.

Available Credit

  • 19.75 Physician Assistants (AAPA)
    DHA J-7 CEPO has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 19.75 hours of AAPA Category 1 CME credits. Approval is valid until Thursday, April 10, 2025 - 11:59pm ET. PAs should only claim credit commensurate with the extent of their participation.
  • 19.75 ACCME Non-Physician CME Credit
    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 19.75 hours for completing this Course activity.
  • 19.75 Physicians (ACCME)

    DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DHA, J-7, CEPO designated this Course for a maximum of 19.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 19.50 Occupational Therapists and Occupational Therapy Assistants (AOTA)
    The DHA, J-7, CEPO is an American Occupational Therapy Association (AOTA) Approved Provider of professional development (PD). PD activity approval ID# 07755. This Blended/Hybrid course is offered at 1.95 CEUs, OT service delivery. AOTA does not endorse specific course content, products, or clinical procedures.
  • 19.50 Physical Therapists and Physical Therapy Assistants (APTA)
    DHA, J-7, CEPO is an American Physical Therapy Association (APTA) Approved Provider of continuing education. This activity was planned by and for the health care team, and learners will receive 1.95 APTA CEUs. The assignment of APTA CEUs does not imply endorsement of specific course content, products, or clinical procedures by APTA. APTA CEUs are accepted by most state PT licensing boards. Learners are encouraged to check with their local chapter or state board to ensure that they accept APTA accredited courses for licensure renewal.
  • 19.50 Speech-Language Pathologists and Audiologists (ASHA)

    Course # is ABIT2504

    Advanced Level

    1.95 ASHA CEUs

    DHA, J-7, CEPO is approved by the Continuing Education board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology, and audiology. ASHA CE Provider approval and use of the Brand Block does not imply endorsement of course content, specific products or clinical procedures.

  • 19.75 Certificate of Attendance
  • 19.75 Interprofessional Continuing Education (IPCE)

    In support of improving patient care, DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the healthcare team, and learners will receive 19.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please login or create an account to take this course.



Requirements: CE/CME certificates are awarded to participants who fully complete the activity, successfully submit the evaluation survey, and pass the posttest. The deadline to claim credit is Apr 10, 2025.

Access Code: Some activities require an access code to register or claim credit. Please contact the organization providing the activity for the access code. The Continuing Education Program Office (CEPO) does not provide access codes.

Accommodations: Please contact the course instructor to inquire about accommodations. For additional technical support, email [email protected].